PremiumThe FlyBioVie files to sell 7.71M shares of common stock for holders BioVie says Parkinson’s Disease clinical trial is fully funded BioVie Raises $3.24 Million in Direct Offering PremiumCompany AnnouncementsBioVie Announces $6 Million Stock Offering and Placement BioVie 2.667M share registered direct offering priced at $2.25 BioVie Secures $6.66 Million Through Direct Offering PremiumThe FlyBioVie receives notice of allowance for U.S. patent covering liquid terlipressin BioVie Bolsters Capital with Public Offering and Warrant Adjustment BioVie Launches Public Offering for Corporate Growth 
